Supplements to slow aneurysm growth and prevent rupture
Part of Heart & circulation clinical trials.
This trial studies whether alpha-ketoglutarate, a supplement, can slow the growth of an abdominal aortic aneurysm and reduce the risk of rupture. It may help people whose aneurysm size is in a specific range by tracking changes over time and watching for safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an abdominal aortic aneurysm below the kidneys, with size 39–49 mm
- You are 50 years or older
- You have no history of supplement allergy and can safely take the study supplement
- You have no mental illness and can follow study instructions and follow-up visits
- You have not had prior surgery in the same aneurysm area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes small abdominal aortic aneurysms (39-49 mm) in Chinese patients to understand how they grow and change over time. It may help doctors decide when treatment is needed.
This trial tests whether a special cell treatment can help stabilize a large abdominal aortic aneurysm (AAA) instead of just watching it grow. You may qualify if your aneurysm is at least 5 cm wide and you are scheduled for standard endovascular repair.
This trial tests a new stent graft device for treating abdominal aortic aneurysms. The device is placed inside the aneurysm to reinforce the artery and prevent rupture, which may help people who are candidates for this minimally invasive procedure.
This study looks at blood and/or scan markers to better understand abdominal aortic aneurysms (AAA). It may help doctors predict risks and guide follow-up or treatment choices.
This trial is testing a special device called the TREO stent graft to treat abdominal aortic aneurysms (a widened artery in the belly). It repairs the aneurysm from inside the blood vessel instead of open surgery, which may mean a faster recovery.
This study is testing a new approach to manage abdominal aortic aneurysms (bulges in the main belly artery). It is for people whose aneurysm is larger than 30 mm but does not have certain rare features that require different care.
Hear when a new Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.